It's the first drug for treatment of the disease in a country with a rapidly aging population.
Developed by Japanese drugmaker Eisai Co. and U.S. biotechnology firm Biogen Inc., the drug's approval in Japan comes two months after it was endorsed by the U.S. Food and Drug Administration.
Prime Minister Fumio Kishida, who announced Japan's approval of Leqembi on Monday, called it “a breakthrough” and said that the “treatment of dementia has now entered a new era.” According to the health ministry, Japan's number of dementia patients who are 65 years of age or older will rise to 7 million in 2025, from the current 6 million.
Eisai said it will conduct a post-marketing special use survey in all patients administered the drug until enough data is collected from unspecified number of patients under Japanese health ministry procedures.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Japan, with 6 million Alzheimer's patients, approves first drug to treat conditionIt's the first drug for treatment of the disease in a country with a rapidly aging population.
続きを読む »
Japan, with 6 million Alzheimer's patients, approves first drug to treat conditionIt's the first drug for treatment of the disease in a country with a rapidly aging population.
続きを読む »
Japan, with 6 million Alzheimer's patients, approves first drug to treat conditionIt's the first drug for treatment of the disease in a country with a rapidly aging population.
続きを読む »
After US approval, Japan OKs Leqembi, its first Alzheimer's drug, developed by Eisai and BiogenJapan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
続きを読む »
After US approval, Japan approves Leqembi, its first Alzheimer's drugJapan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
続きを読む »
After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and BiogenJapan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was...
続きを読む »